Faron Pharmaceuticals
0.51 EUR
-2.31 %
5,676 following
Corporate customer
FARON
First North Finland
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Faron Pharmaceuticals
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26e | Q2/26e | Q3/26e | Q4/26e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | ||||||
| EBITDA | 0.1 | -11.9 | 0.1 | -7.0 | -18.8 | -7.4 | -11.4 | ||
| EBIT (adj.) | -11.9 | -7.1 | -19.0 | -7.5 | -11.5 | ||||
| EBIT | -11.9 | -7.1 | -19.0 | -7.5 | -11.5 | ||||
| EBIT-% (adj.) | -23,818,000.0 % | -14,102,000.0 % | -474,000.0 % | ||||||
| EBIT-% | -23,818,000.0 % | -14,102,000.0 % | -474,000.0 % | ||||||
| Profit before taxes | -19.4 | -7.8 | -27.3 | -10.5 | -12.5 | ||||
| Net income | -19.4 | -7.8 | -27.3 | -10.5 | -12.5 |